PDT Partners’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-151,956
| Closed | -$804K | – | 952 |
|
|
2021
Q2 | $804K | Buy |
+151,956
| New | +$804K | 0.05% | 411 |
|
|
2021
Q1 | – | Sell |
-17,927
| Closed | -$59K | – | 913 |
|
|
2020
Q4 | $59K | Buy |
+17,927
| New | +$59K | ﹤0.01% | 669 |
|
|
2020
Q3 | – | Sell |
-19,692
| Closed | -$66K | – | 893 |
|
|
2020
Q2 | $66K | Buy |
+19,692
| New | +$66K | ﹤0.01% | 643 |
|
|
2019
Q2 | – | Sell |
-87,800
| Closed | -$476K | – | 480 |
|
|
2019
Q1 | $476K | Buy |
87,800
+34,400
| +64% | +$186K | 0.03% | 320 |
|
|
2018
Q4 | $159K | Buy |
+53,400
| New | +$159K | 0.01% | 421 |
|